Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles P Sparrow

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Pharmacology|November 15, 2023
Application of a Precision-Dosing Model to a Real-World Cohort of Patients on Infliximab Maintenance Therapy: Drug Usage and Cost AnalysisAnke L Nguyen, Peter R Gibson, Richard N Upton, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 16, 2024
Clinical utility of C-reactive protein-to-albumin ratio in the management of patients with inflammatory bowel diseaseAnke L Nguyen, Claudia Brick, David Liu, et al.
Journal of Crohn'S & Colitis|October 28, 2017
Anti-TNF Re-induction Is as Effective, Simpler, and Cheaper Compared With Dose Interval Shortening for Secondary Loss of Response in Crohn's DiseaseAshish Srinivasan, Abhinav Vasudevan, Anne McFarlane, et al.
Expert Review of Gastroenterology & Hepatology|October 9, 2024
Therapeutic drug monitoring in inflammatory bowel disease: recent developmentsXavier Roblin, Robert D Little, Nicolas Mathieu, et al.
Journal of Crohn'S & Colitis|September 25, 2019
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-ResponseMiles P Sparrow, Konstantinos Papamichael, Mark G Ward, et al.
Journal of Gastroenterology and Hepatology|February 2, 2025
Review Article: Albumin and Its Role in Inflammatory Bowel Disease: The Old, the New, and the FutureKarla Cameron, Anke L Nguyen, David J Gibson, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2024
Review article: Measuring disease severity in inflammatory bowel disease - Beyond treat to targetAkhilesh Swaminathan, Andrew S Day, Miles P Sparrow, et al.
Alimentary Pharmacology & Therapeutics|May 8, 2020
A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's diseaseAshish Srinivasan, Daniel R van Langenberg, Robert D Little, et al.
Journal of Crohn'S & Colitis|November 10, 2017
Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot StudyLauren Beswick, Ourania Rosella, Gennaro Rosella, et al.
Digestive Diseases and Sciences|December 19, 2018
Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's DiseaseAbhinav Vasudevan, Ajay Raghunath, Shane Anthony, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Pharmacology|November 15, 2023
Application of a Precision-Dosing Model to a Real-World Cohort of Patients on Infliximab Maintenance Therapy: Drug Usage and Cost AnalysisAnke L Nguyen, Peter R Gibson, Richard N Upton, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 16, 2024
Clinical utility of C-reactive protein-to-albumin ratio in the management of patients with inflammatory bowel diseaseAnke L Nguyen, Claudia Brick, David Liu, et al.
Journal of Crohn'S & Colitis|October 28, 2017
Anti-TNF Re-induction Is as Effective, Simpler, and Cheaper Compared With Dose Interval Shortening for Secondary Loss of Response in Crohn's DiseaseAshish Srinivasan, Abhinav Vasudevan, Anne McFarlane, et al.
Expert Review of Gastroenterology & Hepatology|October 9, 2024
Therapeutic drug monitoring in inflammatory bowel disease: recent developmentsXavier Roblin, Robert D Little, Nicolas Mathieu, et al.
Journal of Crohn'S & Colitis|September 25, 2019
Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-ResponseMiles P Sparrow, Konstantinos Papamichael, Mark G Ward, et al.
Journal of Gastroenterology and Hepatology|February 2, 2025
Review Article: Albumin and Its Role in Inflammatory Bowel Disease: The Old, the New, and the FutureKarla Cameron, Anke L Nguyen, David J Gibson, et al.
Alimentary Pharmacology & Therapeutics|October 15, 2024
Review article: Measuring disease severity in inflammatory bowel disease - Beyond treat to targetAkhilesh Swaminathan, Andrew S Day, Miles P Sparrow, et al.
Alimentary Pharmacology & Therapeutics|May 8, 2020
A virtual clinic increases anti-TNF dose intensification success via a treat-to-target approach compared with standard outpatient care in Crohn's diseaseAshish Srinivasan, Daniel R van Langenberg, Robert D Little, et al.
Journal of Crohn'S & Colitis|November 10, 2017
Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot StudyLauren Beswick, Ourania Rosella, Gennaro Rosella, et al.
Digestive Diseases and Sciences|December 19, 2018
Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's DiseaseAbhinav Vasudevan, Ajay Raghunath, Shane Anthony, et al.
Pageof 10